We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GC Medical Science corp.

Download Mobile App




New Technologies Drive Hernia Repair Market

By HospiMedica International staff writers
Posted on 30 Sep 2010
Rapid adoption of biosynthetic mesh and other minimally invasive methods of hernia repair will increase revenues for manufacturers of hernia-repair specialty equipment. More...
These are the latest findings of Kalorama Information (New York, NY, USA), an independent market research firm.

Biosynthetic mesh procedures provide benefits such as better a patient experience, greater resistance to infections and rapid tissue growth. These meshes, made up of silicone, rubber, polypropylene, or polytetrafluoroethylene (PTFE), create a protective layer that comes in contact with the intestine. Former developments include the laparoscopic repair method, widely adopted by 2000, which reduces invasiveness by patching hernias from the inside. Although once widely criticized for its high recurrence rate, continuing development of this procedure has led to a current near-zero rate of recurrence.

An important recent development is the perfection of the T-shaped prosthesis, composed of silicone and polypropylene, which reduces the development of incisional hernias, often caused by previous surgery. While the current average occurrence rate for incisional hernia cases is 15% - 20%, the use of T-shaped prosthesis is expected to reduce this figure to 3% - 4%. As a result, high-risk individuals with factors such as old age, previous surgery, obesity, and smoking, previously excluded from treatment, are expected to increase the number of hernia repair operations. In preparation, major industry players are preparing new products for this growing market.

"Biomesh and no-recurrence laparoscopy are not just small improvements, they are significant innovations,” said Bruce Carlson, the publisher of Kalorama Information. "There is a ton of innovation occurring in this market to meet the increasing demand for better quality.”

According to the Kalorama Information report, these new technologies will expand market sales to US$4.1 billion by 2012.

Related Links:
Kalorama Information


Platinum Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
Enteral Feeding Pump
SENTINELplus
Xenon Light Source
CLV-S400
Infant Incubator
OKM 801
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Professor Bumsoo Han and postdoctoral researcher Sae Rome Choi of Illinois co-authored a study on using DNA origami to enhance imaging of dense pancreatic tissue (Photo courtesy of Fred Zwicky/University of Illinois Urbana-Champaign)

DNA Origami Improves Imaging of Dense Pancreatic Tissue for Cancer Detection and Treatment

One of the challenges of fighting pancreatic cancer is finding ways to penetrate the organ’s dense tissue to define the margins between malignant and normal tissue. Now, a new study uses DNA origami structures... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.